Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.70 |
| ▸ | ACE | P12821 | 4/20 | 0.68 |
| ▸ | ITGB2 | P05107 | 6/20 | 0.67 |
| ▸ | ICAM1 | P05362 | 6/20 | 0.67 |
| ▸ | ITGAL | P20701 | 6/20 | 0.67 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.66 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1994981 | 1.00 | ALOX15 (0.70) | ALOX15ACEITGB2ICAM1ITGAL | |
| SCHEMBL3728145 | 0.90 | ALOX15 (0.70) | ALOX15ACEITGB2ICAM1ITGAL | |
| SCHEMBL29987387 | 0.90 | ALOX15 (0.70) | ALOX15ACEITGB2ICAM1ITGAL | |
| SCHEMBL6313468 | 0.90 | ALOX15 (0.70) | ALOX15ACEITGB2ICAM1ITGAL | |
| SCHEMBL30936746 | 0.90 | ALOX15 (0.70) | ALOX15ACEITGB2ICAM1ITGAL | |
| SCHEMBL13278205 | 0.90 | ALOX15 (0.70) | ALOX15ACEITGB2ICAM1ITGAL | |
| SCHEMBL11495534 | 0.88 | ACE (0.71) | ALOX15ACEITGB2ICAM1ITGAL | |
| SCHEMBL7745569 | 0.88 | ALOX15 (0.68) | ALOX15ACEITGB2ICAM1ITGAL | |
| SCHEMBL4184039 | 0.88 | ALOX15 (0.72) | ALOX15ACEITGB2ICAM1ITGAL | |
| SCHEMBL11495529 | 0.88 | ACE (0.71) | ALOX15ACEITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023069598-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2023-04-27 | — | — | WO | claimed |
| EP-3555615-A1 | MASS SPECTROMETRY ASSAY METHOD FOR DETECTION AND QUANTITATION OF KIDNEY FUNCTION METABOLITES | Metabolon, Inc. (US) | 2019-10-23 | — | — | EP | claimed |
| US-20180214556-A1 | AQUEOUS COMPOSITION COMPRISING AT LEAST ONE PROTEIN AND ONE SOLUBILIZING AGENT, PREPARATION THEREOF AND USES THEREOF | ADOCIA (FR) | 2018-08-02 | — | — | US | claimed |
| WO-2018118630-A1 | MASS SPECTROMETRY ASSAY METHOD FOR DETECTION AND QUANTITATION OF KIDNEY FUNCTION METABOLITES | METABOLON, INC. (US) | 2018-06-28 | — | — | WO | claimed |
| EP-3129909-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | Metabolon, Inc. (US) | 2017-02-15 | — | — | EP | claimed |
| WO-2016025429-A1 | PRECISE ESTIMATION OF GLOMERULAR FILTRATION RATE FROM MULTIPLE BIOMARKERS | THE JOHNS HOPKINS UNIVERSITY (US) | 2016-02-18 | — | — | WO | claimed |
| US-20150335751-A1 | AQEOUS COMPOSITION COMPRISING AT LEAST ONE PROTEIN AND ONE SOLUBILIZING AGENT, PREPARATION THEREOF AND USES THEREOF | ADOCIA (FR) | 2015-11-26 | — | — | US | claimed |
| WO-2015173377-A1 | AQUEOUS COMPOSITION COMPRISING AT LEAST ONE PROTEIN AND ONE SOLUBILIZING AGENT, PREPARATION THEREOF AND USES THEREOF | ADOCIA (FR) | 2015-11-19 | — | — | WO | claimed |
| WO-2015157407-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | METABOLON, INC. (US) | 2015-10-15 | — | — | WO | claimed |
| EP-2914962-A1 | BIOMARKERS OF MULTIPLE MYELOMA DEVELOPMENT AND PROGRESSION | Ospedale San Raffaele S.r.l. (IT) | 2015-09-09 | — | — | EP | claimed |
| WO-2015010137-A2 | BIOCHEMICAL MARKERS OF PLATELET STORAGE | PUGET SOUND BLOOD CENTER (US) | 2015-01-22 | — | — | WO | claimed |
| WO-2014068144-A1 | BIOMARKERS OF MULTIPLE MYELOMA DEVELOPMENT AND PROGRESSION | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2014-05-08 | — | — | WO | claimed |
| WO-2010124269-A1 | METHODS FOR DIAGNOSIS OF SEPSIS AND RISK OF DEATH | NATIONAL CENTER FOR GENOME RESOURCES (US) | 2010-10-28 | — | — | WO | claimed |
| US-11992518-B2 | Molecular vaccines for infectious disease | AGILENT TECHNOLOGIES, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| EP-3965820-A1 | COMPOSITIONS AND METHODS FOR PROMOTING HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY | The Regents of the University of California (US) | 2022-03-16 | — | — | EP | disclosed |
| US-10968269-B1 | MHC multimers in borrelia diagnostics and disease | AGILENT TECHNOLOGIES, INC. (US) | 2021-04-06 | — | — | US | disclosed |
| EP-1430307-A2 | A METHOD OF PROTEIN ANALYSIS | Oxford GlycoSciences (UK) Ltd, Attn: Mary Gadsden (GB) | 2004-06-23 | — | — | EP | disclosed |
| EP-1320754-A2 | DETECTION OF PEPTIDES | Oxford GlycoSciences (UK) Limited (GB) | 2003-06-25 | — | — | EP | disclosed |
| WO-2003027681-A2 | A METHOD OF PROTEIN ANALYSIS | OXFORD GLYCOSCIENCES (UK) LTD (GB) | 2003-04-03 | — | — | WO | disclosed |
| WO-2002025287-A2 | DETECTION OF PEPTIDES | OXFORD GLYCOSCIENCES (UK) LTD. (GB) | 2002-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180214556-A1 | AQUEOUS COMPOSITION COMPRISING AT LEAST ONE PROTEIN AND ONE SOLUBILIZING AGENT, PREPARATION THEREOF AND USES THEREOF | SET, SON, S100A6 | ALOX15 4830/4885ACE 819/4885ITGB2 4868/4885 |
| US-20150335751-A1 | AQEOUS COMPOSITION COMPRISING AT LEAST ONE PROTEIN AND ONE SOLUBILIZING AGENT, PREPARATION THEREOF AND USES THEREOF | ATIC, SON, MAX | ALOX15 4754/4885ACE 525/4885ITGB2 4871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.